Literature DB >> 21681794

Getting to value in neurological care: a roadmap for academic neurology.

Robert G Holloway1, Steven P Ringel.   

Abstract

Academic neurology is undergoing transformational changes. The public investment in biomedical research and clinical care is enormous and there is a growing perception that the return on this huge investment is insufficient. Hospitals, departments, and individual neurologists should expect more scrutiny as information about their quality of care and financial relationships with industry are increasingly reported to the public. There are unprecedented changes occurring in the financing and delivery of health care and research that will have profound impact on the mission and operation of academic departments of neurology. With the passage of the Patient Protection and Affordable Care Act (PPACA) there will be increasing emphasis on research that demonstrates value and includes the patient's perspective. Here we review neurological investigations of our clinical and research enterprises that focus on quality of care and comparative effectiveness, including cost-effectiveness. By highlighting progress made and the challenges that lie ahead, we hope to create a clinical, educational, and research roadmap for academic departments of neurology to thrive in today's increasingly regulated environment.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Year:  2011        PMID: 21681794     DOI: 10.1002/ana.22439

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

1.  Reading a cost-effectiveness or decision analysis study: Five things to consider.

Authors:  Kate C Young; Adam G Kelly; Robert G Holloway
Journal:  Neurol Clin Pract       Date:  2013-10

2.  How much does it cost to identify a critically ill child experiencing electrographic seizures?

Authors:  Nicholas S Abend; Alexis A Topjian; Sankey Williams
Journal:  J Clin Neurophysiol       Date:  2015-06       Impact factor: 2.177

Review 3.  Could EEG Monitoring in Critically Ill Children Be a Cost-effective Neuroprotective Strategy?

Authors:  Nicholas S Abend; Alexis A Topjian; Sankey Williams
Journal:  J Clin Neurophysiol       Date:  2015-12       Impact factor: 2.177

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.